We are live on ! Find out more
DBG

De Burlo Group Portfolio holdings

AUM $441M
1-Year Est. Return 21.21%
This Fund
S&P 500
This Quarter Est. Return
-4.81%
1 Year Est. Return
+21.21%
3 Year Est. Return
+98.05%
5 Year Est. Return
+220.33%
10 Year Est. Return
+1,846.98%
AUM
$426M
AUM Growth
-$51.7M
Cap. Flow
-$20.6M
Cap. Flow %
-4.84%
Top 10 Hldgs %
29.07%
Holding
112
New
8
Increased
28
Reduced
43
Closed
13

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$11.4M
2
CCI icon
Crown Castle
CCI
+$5.45M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$5.4M
4
FTNT icon
Fortinet
FTNT
+$5.12M
5
SBUX icon
Starbucks
SBUX
+$4.84M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$9.01M
2
AAPL icon
Apple
AAPL
+$8.76M
3
SIAL
SIGMA - ALDRICH CORP
SIAL
+$6.44M
4
QRVO icon
Qorvo
QRVO
+$5.01M
5
NXPI icon
NXP Semiconductors
NXPI
+$4.8M

Sector Composition

Rank Sector Weight
1 Healthcare 34.36%
2 Consumer Discretionary 18.93%
3 Technology 18.76%
4 Industrials 8.65%
5 Financials 8.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GILD icon
1
Gilead Sciences
GILD
$165B
$18M 4.23%
183,418
+24,900
+16% +$2.77M
AAPL icon
2
Apple
AAPL
$4.8T
$14.7M 3.44%
531,928
-298,824
-36% -$8.76M
SRCL
3
DELISTED
Stericycle Inc
SRCL
$13M 3.04%
93,088
+16,337
+21% +$2.27M
PANW icon
4
Palo Alto Networks
PANW
$284B
$12.8M 3.01%
447,600
+163,800
+58% +$4.83M
NKE icon
5
Nike
NKE
$64.5B
$12.3M 2.88%
199,900
-10,000
-5% -$566K
MCK icon
6
McKesson
MCK
$97.3B
$11.5M 2.71%
62,325
-5,000
-7% -$1.06M
CVS icon
7
CVS Health
CVS
$137B
$11M 2.59%
114,356
+33,100
+41% +$3.48M
ILMN icon
8
Illumina
ILMN
$27.9B
$10.3M 2.43%
60,446
-5,449
-8% -$1.1M
AGN
9
DELISTED
Allergan plc
AGN
$10.1M 2.37%
+37,185
New +$11.4M
ULTA icon
10
Ulta Beauty
ULTA
$21B
$10.1M 2.36%
61,670
– –
JBLU icon
11
JetBlue
JBLU
$2.03B
$9.11M 2.14%
353,600
+27,600
+8% +$650K
HSIC icon
12
Henry Schein
HSIC
$9.82B
$9.04M 2.12%
173,706
-32,385
-16% -$1.79M
DHR icon
13
Danaher
DHR
$142B
$8.67M 2.04%
151,461
+31,393
+26% +$1.85M
V icon
14
Visa
V
$686B
$8.53M 2%
122,470
+11,870
+11% +$847K
MHK icon
15
Mohawk Industries
MHK
$6.58B
$8.41M 1.97%
46,280
+400
+0.9% +$79.2K
SBUX icon
16
Starbucks
SBUX
$119B
$8.31M 1.95%
146,300
+86,300
+144% +$4.84M
RGA icon
17
Reinsurance Group of America
RGA
$15.8B
$8.3M 1.95%
91,600
– –
COR icon
18
Cencora
COR
$59.1B
$8.22M 1.93%
86,550
-4,750
-5% -$498K
ALXN
19
DELISTED
Alexion Pharmaceuticals
ALXN
$8.14M 1.91%
52,070
-525
-1% -$95.8K
MAR icon
20
Marriott International
MAR
$96.8B
$8.07M 1.89%
118,300
-38,700
-25% -$2.8M
ADBE icon
21
Adobe
ADBE
$93.3B
$7.93M 1.86%
96,500
+7,900
+9% +$640K
CRM icon
22
Salesforce
CRM
$142B
$7.63M 1.79%
109,950
-100
-0.1% -$7.09K
NXPI icon
23
NXP Semiconductors
NXPI
$67.5B
$7.47M 1.75%
85,800
-53,200
-38% -$4.8M
DGX icon
24
Quest Diagnostics
DGX
$23B
$7.1M 1.67%
115,500
-200
-0.2% -$14K
CMD
25
DELISTED
Cantel Medical Corporation
CMD
$7.04M 1.65%
124,100
– –
1
2 3 4 5

Similar funds

ECA
Endeavour Capital Advisors Greenwich, Connecticut $441M AUM 21.38% 1-Year Est. Return
DWML
Decker Wealth Management LLC Nashville, Tennessee $441M AUM
BOA
Birnam Oak Advisors New York $441M AUM 37.12% 1-Year Est. Return
PLU
Performa Ltd (US) Charleston, South Carolina $442M AUM 13.84% 1-Year Est. Return
CPW
Cove Private Wealth Oyster Bay Cove, New York $440M AUM 27.56% 1-Year Est. Return
AWM
Austin Wealth Management Austin, Texas $440M AUM 17.66% 1-Year Est. Return
CAAM
Cape Ann Asset Management London, United Kingdom $440M AUM 96.23% 1-Year Est. Return
SCP
SailingStone Capital Partners Houston, Texas $440M AUM 127.21% 1-Year Est. Return

De Burlo Group's Q3 2015 Portfolio in Review

As of Q3 2015, De Burlo Group held 112 positions worth $426M, down 11% from $478M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

De Burlo Group withdrew a net $20.6M in Q3 2015, closing 13 positions and reducing 43 holdings. Its most notable exit was Biogen, an estimated $9.01M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, De Burlo Group opened a new position in Allergan plc worth $10.1M.

  • De Burlo Group's largest Q3 2015 buy was Allergan plc: 37,185 shares worth $10.1M.
  • De Burlo Group added most to Starbucks in Q3 2015, an estimated $4.84M increase.
  • De Burlo Group's biggest Q3 2015 reduction was Apple, cutting an estimated $8.76M.
  • De Burlo Group fully exited Biogen in Q3 2015, selling an estimated $9.01M.
  • De Burlo Group's ten largest holdings make up 29% of its $426M portfolio in Q3 2015.
  • De Burlo Group opened 8 new positions and closed 13 in Q3 2015.
  • De Burlo Group's portfolio value fell 11% quarter-over-quarter to $426M.

Based on De Burlo Group's 13F filing for Q3 2015, filed 5 Nov 2015.